Another interesting feature shared by several members of the selected transmembrane RGD-containing proteins (endoglin, CDH17, CDH6, ADAM15, and L1CAM) is their involvement in different aspects of cancer, including tumor growth, tumor malignancy, tumor vascularization, metastasis, and cancer progression and prognosis. This evidence concerns the gene CDH17 and cancer.